By Charles Alovisetti, Joshua Kappel, Andrea Golan
Dec 2, 2021
As we wait for federal legalization and/or state-regulated psilocybin markets to emerge, what can a motivated entrepreneur interested in mycelium pursue?
By Michelle Bodian, Jennifer Cabrera, Brandon Kurtzman
Nov 10, 2021
Eight months after New Jersey’s Governor signed the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act into law, we now have an application timeline for adult-use cannabis licenses.
By David M. Ullian, Gabriel Amatruda
Nov 8, 2021
Five years in, the Commonwealth has seen the most significant growth in both the number of cannabis businesses and sales, and the market continues to expand and provide new opportunities.
By Shane Pennington
Nov 4, 2021
The NIDA monopoly on cultivating cannabis for research ended in May 2021. Researchers can now study cannabis from state-legal markets by getting it from one of DEA's newly-licensed cannabis cultivators.
By Andrea Golan, Jace Pohlman
Nov 3, 2021
USPS Final Rule bans e-cigarettes and all vaping products, including those containing hemp-derived ingredients unless a business-to-business or regulatory exception is met.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.